NDC product
Chronic Fatigue Therapy
NDC 17312-170 · TRP Company
Key facts
| Product NDC | 17312-170 |
|---|---|
| Proprietary name | Chronic Fatigue Therapy |
| Nonproprietary name | EPINEPHRINE, GOLD, CHELIDONIUM MAJUS, ECHINACEA, GINKGO, HELLEBORUS NIGER, PHOSPHORIC ACID, SCUTELLARIA LATERIFLORA, THUJA OCCIDENTALIS |
| Substances | SCUTELLARIA LATERIFLORA, THUJA OCCIDENTALIS LEAFY TWIG, GINKGO, CHELIDONIUM MAJUS, EPINEPHRINE, PHOSPHORIC ACID, ECHINACEA, UNSPECIFIED, GOLD, HELLEBORUS NIGER ROOT |
| Dosage form | TABLET, ORALLY DISINTEGRATING |
| Route | ORAL |
| Labeler | TRP Company |
| Product type | HUMAN OTC DRUG |
| Marketing category | UNAPPROVED HOMEOPATHIC |
| Pharmacologic classes | Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE] and 4 more |
| Marketing start | Aug 20, 2018 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: